Clinical trial · Interventional
Sentinel Node Detection in Cervical Cancer
NCT03680833CI-TRIAL-00035042SLNcxcaunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of sensitivity of Sentinel lymph nodes for detecting nodal metastases in cervical cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sentinel Lymph Node Biopsy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sentinel node detection in cervical cancer | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- prospective cohort study
- description
- Prospective cohort study with detection of sentinel lymph nodes followed by a full pelvic lymphadenectomy. Patients will act as their own controls. The intervention is the detection and removal of sentinel lymph nodes
- interventionNames
- Procedure: Sentinel node detection in cervical cancer
Primary outcomes (1)
- measure
- Sentinel node detection in cervical cancer; Sensitivity and negative predictive values for identifying pelvic nodal disease, See detailed study protocol
- timeFrame
- 4-5 years
- description
- Detection of Sentinel nodes followed by full pelvic lymphadenectomy
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Women of age 18 years and older at the time of informed consent. * Women with a pathologically proven cervical carcinoma of any histologic subtype, clinically stage 1a2- 2a1 planned for primary surgery * Absence of any exclusion criteria Exclusion Criteria: * Non consenting patients * Ongoing pregnancy * Inability to understand written and/or oral study information * Who performance status III or more * Previous lower limb lymphedema * Surgical contraindication to a laparoscopic approach or lymphadenectomy at surgeons discretion. * Anesthesiologic contraindication to a laparoscopic approach at the anesthetist's discretion * Locally advanced disease or intraabdominal/distant metastases at preoperative CT, MRI or ultrasonography * Radiologically suspect pelvic nodal metastatic disease according to the RECIST criteria (\>= 1 node with \>=16 mm short axis diameter) * Allergy to Iodine * Patients with a known liver disease * Patients with a significant bleeding disorder or mandatory antithrombotic treatment.
References
Publications (0)
Data not yet available
No reference posted for this study.